ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
62,969.56
-1.21%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Candel Therapeutics Inc (CADL) Quote

Candel Therapeutics Inc

Candel Therapeutics Inc (CADL)

NASDAQ
6.39
-0.04
(-0.62%)
Closed April 27 4:00PM
Delayed by 15 minutes
6.56
0.17
(2.66%)
After Hours: 7:59PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
6.56
Bid
6.56
Ask
6.66
Volume
391,978
6.02 Day's Range 6.60
0.66 52 Week Range 11.3999
Market Cap
185.087M
Previous Close
6.43
Open
6.60
Last Trade
1
@
6.56
Last Trade Time
Financial Volume
$ 2,503,506
VWAP
6.3869
Average Volume (3m)
5,719,720
Shares Outstanding
28,919,810
Dividend Yield
-
PE Ratio
-4.88
Earnings Per Share (EPS)
-1.31
Revenue
-
Net Profit
-37.94M

About Candel Therapeutics Inc

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.candeltx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Candel Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CADL. The last closing price for Candel Therapeutics was $6.43. Over the last year, Candel Therapeutics shares have traded in a share price range of $ 0.66 to $ 11.3999.

Candel Therapeutics currently has 28,919,810 shares outstanding. The market capitalization of Candel Therapeutics is $185.09 million. Candel Therapeutics has a price to earnings ratio (PE ratio) of -4.88.

CADL Latest News

More News

Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

NEEDHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...

April 25 2024
GlobeNewswire Inc.

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

NEEDHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...

April 11 2024
GlobeNewswire Inc.

Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

First-in-class multimodal immunotherapy candidate, for induction of tertiary lymphoid structures, being developed as a novel therapeutic strategy for solid tumors from the enLIGHTEN™ Discovery...

April 09 2024
GlobeNewswire Inc.

Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

Updated positive interim data showed notable improvements in estimated median overall survival of 28.8 months after experimental treatment with CAN-2409 versus only 12.5 months in control group in...

April 04 2024
GlobeNewswire Inc.

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

The first cohort of patients were treated with multiple injections of CAN-3110 in the ongoing phase 1b clinical trial.The serial procedures were well tolerated without observed dose-limiting...

March 28 2024
GlobeNewswire Inc.

Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights

On track for topline data from CAN-2409 phase 3 in localized intermediate/high risk prostate cancer, expected in Q4 2024Results from ongoing, first-in-human, phase 1b clinical trial of CAN-3110...

March 28 2024
GlobeNewswire Inc.

Form 8-K - Current report

March 06 2024
Edgar (US Regulatory)

Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate

NEEDHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...

March 05 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.1220.58823529415.446.815.055959255.87124428CS
44.84281.3953488371.7211.39991.56172335386.59585166CS
125.22389.5522388061.3411.39991.2157197206.53247288CS
265.63605.3763440860.9311.39990.6629351206.00663054CS
525.02325.9740259741.5411.39990.6614668205.97105849CS
156-1.44-18814.780.665662105.97666975CS
260-1.44-18814.780.665662105.97666975CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

CADL Discussion

View Posts
skidoo31 skidoo31 1 week ago
Short squeeze coming soon, mm have been borrowing my shares.
👍️0
PonkenPlonken PonkenPlonken 1 week ago
agree. mcap should be 1bln $+++.
institutions are waiting on the bid- then do the lifting on liquidity event.

LOTS of retail antihero-themed traders are short. Weak line of defense.
👍️0
Roadtojourney Roadtojourney 1 week ago
I cant believe this is still sitting at 5. The orphan designation for pancreatic itself is huge. Makes no sense. Imo
👍️0
PonkenPlonken PonkenPlonken 1 week ago
$CADL GROUNDBREAKING data... never before.
see latest presentation regarding pending data in nsclc and CRC
Check Paul Peter Tak vita... Its a home run
👍️0
skidoo31 skidoo31 2 weeks ago
Good job, she’s got legs. Maybe it will cool off in the morning for another possible dip then it’s chart making time. Shorts are staying away from this one as the potential for blue sky breakout is very good.
👍️0
Namaste Charting Namaste Charting 2 weeks ago
$cadl. The next few hours should be engaging to say the least
👍️0
Actualfactual Actualfactual 2 weeks ago
Looking for a push towards previous double top of 11.30’s and then a breakout through to blue skies
👍️0
Namaste Charting Namaste Charting 2 weeks ago
Sure is! Added some $cadl $6.50's here

She's got that look!
👍️0
skidoo31 skidoo31 2 weeks ago
https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-receives-fda-orphan-drug-designation-can
👍️0
skidoo31 skidoo31 2 weeks ago
Chart is building nicely ..
👍️0
Awl416 Awl416 2 weeks ago
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
👍️0
philaya philaya 3 weeks ago
Short interest 0.89%...
Bears smarter than some.
👍️0
philaya philaya 3 weeks ago
Will buy...
Any time low good.
👍️0
Roadtojourney Roadtojourney 3 weeks ago
Thats it just goes up news and then sell on news?? There is no holding here??
👍️0
skidoo31 skidoo31 3 weeks ago
Could be a blue sky breakout if all these fundamentals line up. Big potential here.
👍️0
skidoo31 skidoo31 3 weeks ago
New here, do you have a link please? Thank you
👍️0
stoxjock stoxjock 3 weeks ago
I am Getting Ready for tomorrow's Blast-off Opening at $15+, as we could possibly see news at 8:30AM about a 'Private Placement' of maybe 5M Common shares 'Unit's @$15.00/share Plus each Warrant in the unit exercisable at $15/common share, upon dosing of the 1st Patient in the Phase 3 trial...with total 'Net proceeds' of around $140M giving Runway to EOY 2026!
👍️0
stoxjock stoxjock 3 weeks ago
This stock was 'walked down' in PPS Friday afternoon. I am fully loaded. This is going to move up north of $30+ next two months. It has catalyst "READOUTs' coming up next two months and then into 4rth Q. Do not sell out for peanuts profits if you want to make massive gains, just HODL it till EOY 2024.Also, very possible it could be taken out anytime...GLTA!
👍️0
philaya philaya 3 weeks ago
Fund easy...
With the positive meds.
👍️0
Roadtojourney Roadtojourney 3 weeks ago
All that volume and only up 3% lol??
👍️0
philaya philaya 3 weeks ago
fomo monday...
fun to watch.
👍️0
philaya philaya 3 weeks ago
friday selling...
nothing matter.
👍️0
Monksdream Monksdream 3 weeks ago
CADL new 52 hi
👍️0
philaya philaya 3 weeks ago
buy the dip...
got some.
👍️0
Awl416 Awl416 3 weeks ago
Hilarious
👍️0
Awl416 Awl416 3 weeks ago
LOL
👍️0
Invest-in-America Invest-in-America 3 weeks ago
CADL: See latest 'CHART', below!!!!
👍️0
Awl416 Awl416 3 weeks ago
This action is entertaining
👍️0
axelvento axelvento 3 weeks ago
ALERT- Cash Position: Cash and cash equivalents as of December 31, 2023 were $35.4 million, as compared to $70.1 million as of December 31, 2022. Based on current plans and assumptions, the Company expects that its existing cash and cash equivalents will be sufficient to fund its current operating plan into the fourth quarter of 2024
👍️0
axelvento axelvento 3 weeks ago
Phase 2 topline data for CAN-2409 in low-to-intermediate-risk, localized, non-metastatic prostate cancer expected in Q4 2024
Phase 3 topline data for CAN-2409 in localized intermediate/high-risk prostate cancer expected in Q4 2024
👍️0
trader59 trader59 3 weeks ago
The dump here when the computers doing the trading are turned off is going to be brutal.
👍️0
TIMGZ TIMGZ 3 weeks ago
you are very good at taking risk, that is why u are so rich. what about if it dips at 4a.
did you catch it early?
👍️0
2020trader 2020trader 3 weeks ago
expecting lower
👍️0
Invest-in-America Invest-in-America 3 weeks ago
CADL: Easiest money of the week, that's for sure, Capt. Tim!!! (And I'm still holding it all.)
👍️0
TIMGZ TIMGZ 3 weeks ago
nice try****so far almost 500%*****
👍️0
da_stock_analyst da_stock_analyst 3 weeks ago
#CADL 🔥 insane run today! What about tomorrow? $cadl
👍️0
Monksdream Monksdream 3 weeks ago
You mean like when I bought GDDY
👍️0
dinogreeves dinogreeves 3 weeks ago
Very true Monk, if one doesn't have a plan, most likely will lose it all.
👍️0
Monksdream Monksdream 3 weeks ago
Quite often today’s hero is next day’s zero
Price is what you pay; value is what you get
👍️0
dinogreeves dinogreeves 3 weeks ago
Congrats on whoever scored here.
👍️0
Monksdream Monksdream 3 weeks ago
Runaway freight train
Reminds me of my TOP trade where I made 25x money
👍️0
glenn1919 glenn1919 3 weeks ago
CADL.............................................a/h.........$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
philaya philaya 3 weeks ago
Not selling ...
Insane luck calling.
👍️0
GhosTraderX GhosTraderX 3 weeks ago
Kaboom After Hours...

Hopped out at 10.00

Bought at 2.00 out at 10.00

Got a little lucky too...

GhosT
👍️0
Awl416 Awl416 3 weeks ago
120m moved it 5 bucks and 5m moved it 3 bucks after hours

Scary

👍️0
Zorro Zorro 3 weeks ago
Nice call!
👍️0
Awl416 Awl416 3 weeks ago
Professional short squeeze LOL
👍️0
Awl416 Awl416 3 weeks ago
LOL
👍️0
GhosTraderX GhosTraderX 3 weeks ago
After Hours could get crazy...

I holding, betting it will Rocket...

GhosT
👍️0
GhosTraderX GhosTraderX 3 weeks ago
Beast Mode here...

Bought in this morning...

Still holding...

GhosT
👍️0

Your Recent History

NASDAQ
CADL
Candel Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved